EP 4232605 A2 20230830 - METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING PROSTATE CANCER BASED ON LONG NONCODING RNA OVERLAPPING THE LCK GENE THAT REGULATES PROSTATE CANCER CELL GROWTH
Title (en)
METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING PROSTATE CANCER BASED ON LONG NONCODING RNA OVERLAPPING THE LCK GENE THAT REGULATES PROSTATE CANCER CELL GROWTH
Title (de)
VERFAHREN UND ZUSAMMENSETZUNGEN ZUR DIAGNOSE UND BEHANDLUNG VON PROSTATAKREBS AUF BASIS VON LANGER NICHTCODIERENDER RNA, DIE DAS LCK-GEN ÜBERLAPPEN, DAS PROSTATAKREBSZELLWACHSTUM REGULIERT
Title (fr)
MÉTHODES ET COMPOSITIONS POUR DIAGNOSTIQUER ET TRAITER UN CANCER DE LA PROSTATE SUR LA BASE D'UN ARN LONG NON CODANT CHEVAUCHANT LE GÈNE LCK RÉGULANT LA CROISSANCE DES CELLULES DU CANCER DE LA PROSTATE
Publication
Application
Priority
- US 202017095511 A 20201111
- US 2021059022 W 20211111
Abstract (en)
[origin: WO2022103988A2] Provided herein is a previously unannotated IncRNA lying within exon six and 3'UTR of the LCK gene, labeled "HULLK" for Hormone-Upregulated IncRNA within LCK. HULLK is a novel IncRNA situated within the L C K gene that can serve as an oncogene in PCa. Accordingly, provided are methods and compositions for diagnosing and treating prostate cancer based on HULLK that regulates prostate cancer cell growth.
IPC 8 full level
C12Q 1/6886 (2018.01); C12Q 1/686 (2018.01)
CPC (source: EP)
C12Q 1/6886 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/158 (2013.01)
Citation (search report)
See references of WO 2022103988A2
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2022103988 A2 20220519; WO 2022103988 A3 20220616; EP 4232605 A2 20230830
DOCDB simple family (application)
US 2021059022 W 20211111; EP 21892828 A 20211111